Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
15 August 2022 |
Main ID: |
NCT02588807 |
Date of registration:
|
27/10/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis
ALS-PHL |
Scientific title:
|
The Combination of Phospholipids and Medical Herbs for the Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS); A Pilot Study |
Date of first enrolment:
|
January 1, 2021 |
Target sample size:
|
0 |
Recruitment status: |
Withdrawn |
URL:
|
https://clinicaltrials.gov/show/NCT02588807 |
Study type:
|
Interventional |
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
Phase 1
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Jacob Meer, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Carmel Medical Center |
| | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|